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Cytokines are hormones that carry information from ceJI to ceH. This information is read 
from their surface upon binding to transmembrane receptors and by the subsequent 
initiation of receptor oligomerization. An inftuence on this process through mutagenesis on 
the hormone surface is highly desirab)e for medical reasons. 
However, an understanding of hormone-receptor interactions requires insight into the 
structural changes introduced by the mutations. In this line structural studies on human 
TL-4 and the medically important IL-4 antagonists YI24D and Y124G are presented. The 
site a.round YI24 is an important epitope responsible for the a.bility of 11-4 t.o ca.use a signal 
in the target cells. It is shown that the local main-chain structure around residue 124 in the 
variants remains unchanged. A strategy is presented here which allows the study of these 
types of proteins and their variants by NMR which does not require carbon Iabeiied 
sa.mples. 
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1. Introduction 
lnterleukin-4 (IL-4i) controls the growth and 
differentiation of a number of cells in the immune 
system (Paul & Ohara, 1987; Paul, 1987, 199f; 
Jansen et al., 1990; Finkelman et al., 1990, 1991) by 
acting on receptors of the haematopoietin super-
family (Bazan, 1990a,b; Cosman et al., 1990). It 
belongs to a group of smaller cytokines with a 
molecula.r weight araund 15 kDa. together with 
interleukin-3, interleukin-5 and the granulocyte 
macrophage-colony stimulating factor (GM-CSF) 
(Boulay & Paul, 1992), and in contrast to, for 
example, the )arger human growth hormone (hGH), 
erythropoietin and interleukin-6. IL-4 is secreted by 
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c1ass 2 helper T -lymphocytes, mast cells and thymo-
cytes. Its major function is t.he Stimulation of acti-
vated B-cells, and the initiation of the proliferation 
of T lymphocytes, thymocytes and mast cells 
(Defrance et al., 1987). IL-4 acts also as an isotype 
switching factor in conjunction with interleukin-2 
and interferon-y in immunoglobuJin-mediated 
immune responses, discriminating between lgE and 
IgGI (de Vries et al., 1991; Vitetta et al., 1985; 
Coffman et al., 1986). This fact may be exploited for 
the treatment of allergic diseases (Burstein et al., 
1991 ). Another important action of IL-4 is the 
induction of cytotoxic CDs-+ T cells, which may 
serve as a basis for cancer therapy ( Dullens & 
DeWit, 1991; Tepper et al., 1989, 1992). 
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Mutagenesis experiments on IL-4 have been per-
formed in order to characterize the regions impor-
tant for its activity (Kruse et al., 1991, 1994; 
Morrison & Leder, 1992) and to find variants with 
an antagonistic activity profile (Kruse et al., 1992). 
The variants showed either reduced binding affinity 
or were not able to activate the receptor, indicating 
a separation between binding and signalling. 
Mutagenesis sturlies of IL-4 related proteins to 
characterize the receptor binding sites have also 
been reported, e.g. interleukin-2 (Cantrell et al., 
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1988; Weigel et al., 1989; Zurawski & Zurawski, 
1989), growth hormone (Cunningham & Wells, 1989, 
1991; Cunningham et al., 1991), GM-CSF and inter-
leukin-5 (Sanderson et al., 1988; Shanafelt et al., 
1991; Sakamaki et al., 1992). 
Structural investigations have shown IL-4 as a 
four-helix bundle with an up-up-down-down 
arrangement of the four helices (Redfield et al., 
1991). Four detailed structures of IL-4 have been 
published so far (Smith et al., 1992; Wlodawer et al., 
1992; Powers et al., 1992b; Walter et al., 1992a), 
showing strong structural similarity between IL-4 
and others such as GM-CSF (Diederichs et al., 1991; 
Walter et al., 1992b), IL-2 (Matt et al., 1992; McKay, 
1992) and, to some extent, hGH (de Vos et al., 1992). 
At present, only one IL-4 receptor molecule is 
fully charact.erized, comprising a. single polypeptide 
chain of ~ 800 amino acid residues (Mosley et al., 
1989; Galizzi et al., 1990; Harada et al., 1990; 
Idzerda et al., 1990). It occurs at the relatively low 
flgure of 150 to 2500 molecules per target cell 
(CabriJlat et al., 1987; Park et al., 1987). A single 
dissociation constant of ::::: 100 pM has been deter-
mined for the receptor-cytokine interaction. The 
IL-4 receptor is evolutionarily related to the large 
family of haematopoietin receptors, including recep-
tors (or receptor subunits) for interlenkins 2, 3, 5, 6 
and 7, for GM-CSF and G-CSF and also for erythro-
poietin, growth hormone and prolactine (Bazan, 
1990a,b; Cosman et al., 1990). Recently, a second 
IL-4 receptor, which shows low affinity binding to 
IL-4 has been isolated from pre-B cells, but there is 
only limited sequence data available (Fanslow et al., 
1993). 
The initiation of the signal transduction chain by 
the lymphokines is thought to proceed through 
oHgomerization of at least two Jike or two unlike 
transmembrane receptor molecules, where the 
hormone interacts with the outer cell components, 
and the signal is transmitted to inside the celJ upon 
oligomerization (Bazan, 1990a; Watowich et al., 
1991; Cunningham et al., 1991). The positions ofthe 
receptor binding sites on the lymphokines deduced 
from mutagenesis studies were supported by the 
structure of the hGH receptor complex (de Vos et 
al., 1992) in which it is seen that one of two like 
receptor molecules binds to the A-C face of the four-
heJix bundle, and the other to the A-D face. For 
interleukin-3, interleukin-5 and GM-CSF, it is 
known that an a-subunit of a heterodimeric receptor 
binds specificaJJy to the hormone, and that the 
ß-subunit forms a complex only with the hormone/ 
IX-chain adduct (Hayashida, 1990; Fukunaga et al., 
1990; Kastelein & Shanafelt, 1993). In the past it 
has been proposed that IL-4 mediates the dimer-
ization of two like receptor molecules, as has been 
established for the growth hormone (Paul, 1991; 
Bamborough et al., 1993; Wlodawer et al., 1993). 
However, the formation of homodimers has not yet 
been demonstrated for the high-affinity IL-4 
receptor reported to date. Also, with the advent of a 
second IL-4 receptor (Fanslow et al., 1993), a hetero-
oligomeric system becomes more Jikely. 
In the light of this discussion and with the aim of 
designing further potential antagonists, the 
following issues are addressed in this paper: (1) a 
characterization of the major epitope responsible for 
signaHing through the investigation of the varian ts 
Yl24G and Yl24D; (2) the identiflcation of further 
residues building the epitopes responsible for 
receptor binding; and (3) a characterization of the 
mode of receptor oligomerization, in particular, 
with respect to the potential formation of homo- or 
heterodimeric receptor complexes. 
Thus, the structure of IL-4 and the results of the 
investigations of the variants are discussed in terms 
of possible modes of hormonefreceptor interactions. 
This discussion is based on the strong sequence 
similarity between the known IL-4 receptor and the 
huinan growth hormone receptor, for which struc-
tural data are available. 
2. Materials and Methods 
A method was employed for the structural investi-
gation of the wild-type IL-4 and the variants Y124D and 
Yl24G which does not rely on 13C-labelling as commonly 
used for such proteins (Powers et al., 1992a; Garrettet al., 
1992). Jnstead, a set of 15N-NOESY HMQC, 15N-TOCSY 
HMQC (Marion et al., 1989) and 3D-TOCSY-NOESY 
(Oschkinat et al., 1990) spectra was used for the assign-
ment of the resonances and the interpretation of the 
NOESY spectra. Most of the distances were determined 
from short mixing time NOESY spectra, enabling a more 
precise quantification of the NOEs. This approach was 
chosen to allow the investigation of those variants which 
are only expressed at low Ievels in Escherichia coli. The 
disadvantage of this method isthat a smaller number of 
NOE is available in cases of severe spectral overlap, but 
this may be partly compensated for by the more precise 
measurement of the NOE which are available. 
(a) Samples 
Three samples of wild-type IL-4 were prepared. Two 
samples contained unlabelled IL-4, one was uniformly 
15N-labelled. Buffer conditions were 45 mM Na0Ac-d3, 
I0%2H 20/90%H20, 0·2o/0 NaN3 , at pH 5·3. One 
unlabelled sample contained 10 mg IL-4 in 600 Jll, the 
15N-Iabelied sample contained 14 mg IL-4 in 600 IJI butfer. 
The second unlabelled sample contained 40 mg IL-4 in 
1·2 ml with the same buffer, but at pH 5·5 and was 
measured in a 8 mm NMR tube. More dilute samples were 
prepared of the variants Yl24G and Yl24D. For the 
variant YI24G, 18 mg of protein were dissolved in 1·2 ml 
of buffer, and 12 mg in 600 J.d buffer for the variant 
Y124D. 
(b) NM R measurement:~ 
All measurements were performed on a Bruker 
600 MHz AMX spectrometer at 303 K, if not specified 
otherwise. TPPI was applied to achieve quadrature detec-
tion in the virtual dimensions. The 8 mm samples were 
measured on a commercial 8 mm selective 1H probe 
(Bruker). The wild-type sample, in the 8 mm tube, was 
used to measure a set of 2D-spectra: COSY (Aue et al., 
1976), TOCSY (tm=27 ms) (Griesinger et al., 1988), 
NOESY (tm = 10, 20 ms, with a long relaxation delay), all 
with presaturation1 NOESY (1111 = 80 ms) w:ith a jump-
return read pulse (Jeener et al., 1979), and a 3D-TOCSY-
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NOESY {tmTOCSY =27 ms, tmNOESY = 100 ms} spec-
trum. The 2D spectra were typically recorded with a 
spectral width of 8333Hz, 1024/2048 data points in t 1/t2 , 
and using a B1-field of 20 kHz for the TOCSY experi-
ments. Zero quantum coherences were not suppressed in 
the NOESY spectra. The TOCSY -NOESY spectrum was 
recorded with 208/208/512 data points in ttft2 jt3 , and with 
16 scans per increment. This experiment took 7 days. 
TOCSY, NOESY, 15N-NOESY-HMQC (t111 = 120 ms) 
and 15N-TOCSY-HMQC ('t'm= 25 ms) spectra were 
recorded on the labe11ed wild-type sample. For the 
1
'N-NOESY-HMQC spectrum, 256/96/1024- data points 
were recorded in F 1/F 2/F 3 , whereas 256/96/512 data 
points were recorded for the 15N-TOCSY-HMQC. In the 
latter case, only the NH-region was recorded in F ~­
A spectral width of 3164·6 Hz was chosen for the nitrogen 
dimension. 
A set of 2D spectra as described above was also 
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recorded on the unlabelled wifd~type sample, in the 5 mm 
tube, at 308 K. 
The TOCSY-XOESY spectrurn was processed in 
subcubes of the 512/512/512 data points used for t.he 
whole spectrum. T~inear prediction was applied to predict 
data. points up to double the number of those recorded, 
and extensive baseline correction was applied to all 3 
dimensions. The heteronuclear 3D-spectra were typically 
processed in subcubes of the 1024/256/1024 data points 
used for the full spectrum. 
The 20 ms NOESY spectrum used for the quantitative 
evaluation was processed with the application of a 
Lorentz-to-Gauss transformation and zero-filled up to 
4096 data points in both dimensions to obtain optimal 
line shapes. Baseline corrections were applied using a 
polynomial of order 5. Cross peaks were integrated using 
the program AURELIA (Neidig et al., 1990). As an 
example for the quality of the 20 ms NO.ESY data, the 
3.5 
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Figure 1. Region of the NOESY spectrurn (tm=20 ms) showing cross peaks involving C2 H and methyl groups. The 
distances obtained from comparison of the signal intensities with those of reference XOE are given in parentheses. 
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region with the C6H in F 1 and the low-field methyl groups 
in F 2 is shown in Figure l. 
(c} Spectral assignments 
The assignment of the spin systems and the sequential 
assignments were obtained by conventional evaluation of 
COSY, TOCSY, and 15N-NOESY-HMQC spectra tagether 
with the 15N-TOCSY-HMQC spectrum (Marion et al., 
1989). The evaluation of the TOCSY-NOESY spectrum 
helped to complete the assignment. Approximately 60 
NOE of the Na:N- and aNN-type (Oschkinat et al., 1990) 
were used for the sequential assignment, supplementing 
the data from the heteronuclear spectra. The results 
obtained werein line with the assignments reported in the 
Iiterature (Redfield et al., 1991; Powers et al., l992b) 
except that the assignment of the methyl group proton 
resonances of A49 was very differenttothat obtained by 
Powers et al. In our spectra, the proton methyl signal 
occurs at a chemical shift of 0·28 p.p.m. It was assigned 
by means ofCOSY, TOCSY and NOESY cross peaks, and 
showed an unexpectedly large line width. 
(d) Assignment of NOE 
The NOE involving the amide protons were largely 
assigned using the 1 5 N -separated 3D-spectra. Other NOE 
were assigned with the help of a 3D-TOCSY-NOESY 
spectrum, which was evaluated using F tfF 2-slices 
(TOCSY slices}. It turned outtobe most practical to scan 
the NOESY spectrum along the F 2-axis and to evaluate 
for each p.p.m. value the corresponding slices from the 3D 
spectrum with the same F 3-co-ordinate. An NOE with a 
certain F 1-frequency in the 2D-spectrum was then 
assigned by means of the 3D cross peaks in the F 1/F 2 slice 
with the same Frfrequency. As a result, always one 
partner involved in the NOE (the one precessing in t 1 of 
the NOESY sequence) was characterized by 2 frequencies. 
In this way, assignments from the 2D TOCSY spectrum 
were used to assign the 3D-spectrum and the 2D NOESY. 
The assignment was unique when the signal in F 3 (or F 2 
in the NOESY) was not overlapped by others in the 1D-
spectrum, and the used TOCSY cross peak not super-
imposed by others in the 2D spectrum. In the case of 
overlapping signals in F 3, slices taken at the F 3 position 
of the partner involved in the NOE were inspected. It is in 
fact the symmetrical NOESY peak which is then observed 
to be dispersed into the third dimension by a coupling 
partner. This situation is similar to that which oecurs 
during the evaluation of 13C-NOESY HMQC spectra. A 
slice of the 3D-TOCSY -NOESY spectrum taken at the 
F3 -frequency of the V29 methyl group at 0.61 p.p.m. and 
the whole aliphatic region in F 1/F 2 is shown in Figure 2. 
The signals belanging to the high-tield methyl group of 
V29 show a number of NOE, which are mostly to Leul09, 
as indicated. 
(e) Quantijication of NOE 
A build-up series of NOESY spectra was recorded to 
monitor the NOE curve for different types of NOE, e.g. 
NOE between geminal protons or between protons in the 
aromatic rings of the tyrosines. lt turned out that a linear 
interpretation of the amplitudE>,s was still possible in the 
spectrum recorded with a mixing time of 20 rns. The NOE 
from the 20 ms NOESY spectrum were then calibrated 
with rE>,spect to averaged reference NOE of the sametype 
(e.g. NH-aliphatic, aliphatic-CH3, etc). The following 
NOE were chosen as references: NOE between the amide 
protons in the side-chains of glutamine or asparagine; 
NOE inside the aroma.tic ring of the tryptophane; the 
NOE between two cPH, NOE between a'H and methyl 
groups in alanines or CPH and methyl groups in threo-
nines; the NOE between arornatic protons in tyrosines; 
and the NOE between the methyl groups in valine or 
leucine. The largest distances observed varied from 3·0 A 
(NH-NH type) to 4·2 A (aromatic-methyl NOE). 
The error on the determined distances is composed of a 
statistical error due to spectral noise or artifacts, and 
systematical errors. For the latter, 2 major sources are 
expected: the effective correlation times for the inter-
nuclear vectors should vary over the protein, and the 
"initial rate approximation" could already be violated for 
some types of reference NOE. The variation of the local 
correlation time was therefore determined for a number of 
well-resolved reference NOE (around lO) for each type. 
The standard deviation was below O·l A except in one 
case; only the references taken from alanines and threo-
nines showed a !arger standard deviation ( <0·15 A). This 
is an unexpected result, as at least" the side-chains of the 
asparagines and glutamines were expected to show 
different modes of motion. It was interpreted as an indica-
tion that the effective correlation times for the inter-
nuclear vectors are relatively similar for most of the 
residues in this 4-helix bundle protein, inclusive of the 
loop regions. A quenching of NOE was therefore not 
expected to be a major problern and lower bounds were 
used in the calculations. However, this approach is applic-
able only in this case due to the rigidity of the overall 
structure, where even the loops connecting the helices 
show only an intermediate degree of fiexibility. Some 
classes of reference NOE were compared with each other 
to check whether the initial rate approximation was 
already violated. However, only negligible deviations 
were found. 
For shorter distances ( < 3 A} between backhone atoms 
(NH-NH, C11H-NH} error Iimits of ±0·15 A ·were used. 
These relatively narrow error margins were chosen 
because the values of the reference NOEs showed a small 
standard deviation and these kind of distances should be 
less affected by local motions. For the other distances 
error Iimits ranging from ± 0·21 A (for distances below 
3 A not involving methyl groups) up to ±0·35 A were 
used. The amplitudes of the cross peaks which could not 
be integrated due to partial spectral overlap were esti-
mated by comparison with non-overlapped peaks. Much 
larger error Iimits were used for those, ranging from 
±0·4 A to ±0·6 A. A number of constraints were taken 
from the 15N-NOESY-HMQC spectrum or from the 
NOESY spectrum with a mixing time of 80 ms; they were 
used in the calculations as upper Iimits only, and generous 
error margins were used. In total, 583 integrated and 248 
estimated NOE were taken from the 20 ms NOESY spec-
trum, and 197 upper Iimit NOEs were taken from the 
spectra with Ionger mixing times. 
(f} Structure calculation 
The structures were calculated using the program 
XPI..OR (Brünger, 1992). Prior to each calculation, an 
individual extended starting structure was generated. 
Apart from the NOE Iist, 120 mild dihedral angle 
restraints based on coupling constant information (J HH 
TOCSY experiment) (Willker & Leibfritz, 1992) were 
included in the calculation. No hydrogen bond constraints 
were used. Standard 2-step simulated annealing protocols 
were applied (Nilges et al., 1991) including floating assign-
ment. The first step consisted of 25,000 steps high-
temperature dynamics (timestep 0·005 fs) at 2000 K, 
followed by a ·cooling to 300 K and then energy minimiza-
tion. In this phase, disulphide bonds were removed and 
substituted by appropriate NOE. The NOE forces were all 
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Figure 2. F 1/F 2-slice from the TOCSY -NOESY spectrum taken at the F 3-chemical shift of the low-field methyl group 
of Val29. 
scaled down at the beginning, and then slowly increased. 
The second step of the protocol consisted again of a 
simulated annealing period (8000 steps at 2000 K, 
timestep 0·005 fs), followed by 10,000 steps of cooling, in 
which the repulsive non-bonded interactions were scaled 
up to a normal Ievel, and disulphide bonds included. 
A total of 70 structures of the wild-type were calculated, 
of which 32 were selected on the basis of the lowest global 
and NOE energy violations (770 and 450 kcaljmol A 2 , 
respectively). In all, 40% of the selected structures 
showed no NOE violations }arger than 0·4 A, for all the 
other selected structures 1 or 2 violations in different 
places were observed. 
3. Results 
(a) Wild-type structure 
The structures (Figure 3) of the wild-type IL-4 
show a classical four helix-bundle topology with an 
up-up-down-down arrangement of the helices 
(named A,B,C,D in sequential order). Two long 
loops occur between helices A and B, and C and D, 
respectively. These cross over each other and form a 
short ß-sheet at that point. The helices and the 
hydrophobic side-chains adopt rather well defined 
posi tions, as well as the ß-sheet and some parts 
of the loops. The root-mean-square differenee 
(r.m.s.d.) of the c«-positions per residue between the 
32 different structures is around 0·5 A for the 
cx-helical regions, the ß-sheet, and the loop between 
the ß-sheet and helix D (Table 1 ). All other loops are 
more disordered in our calculations, the r.m.s.d. per 
residue being around 2·5 A. The least defined region 
comprises residues 37 to 39 and has a local r.m.s.d. 
of 3·5 A. The side-chains of the hydrophilic amino 
acids are primarily located at the surface of the 
protein, so that only a few of them adopt defined 
positions in our structure. The structure agrees with 
those already reported.. Large r.m.s.d. values are 
obsenred in those areas where an increased mobility 
was detected in the dynamics measurements of 
Redtield (Redfield et al., 1992). 
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Figure 3. C"-plot of interleukin-4 including the side-chains of the hydrophobic amino acids (stereoplot). A total of 32 
structures is shown. 
A minimized average structure of the 32 calcu-
Jated structures shown in Figure 3 was compared to 
the average structures of the two NMR investi-
Table 1 
A. Number of constraints 
NOE 1028 
Intra-residue 259 
Sequentia) (i,i + I) 391 
Medium range (i,i + 2,3} 170 
Long range 208 
Dihedral angles 146 
ß. Structural statistics 
Deviations from idealized covalent geometry 
Bonds (A) (}045 
Angles ()-54° 
lmpropers (}40° 
NOE violations (A) 0·091 
(0·000058) 
(0·011) 
(0·02) 
(0·0014) 
r.m.s.d. from the minimized average structure (mean value a.nd 
sta.nda.rd deviations, backhone atoms) (A) 
Helix A (5-19} 0·39 
Helix ß (41-59) 0·40 
Helix C (7-93) 0·48 
Helix D (109-125) 0·25 
All helices 0·62 
Residues 5-125 1·92 
C. Structure comparison 
IITL-+lRCß 
5-125, bb 
All helices, bb 
88-98, bb 
dto, all hea.vy 
atoms 
5-14, 116·125, bb 
dto, all heavy 
atoms 
(A) 
1·59 
1·27 
1·00 
2·83 
(}69 
1·83 
bb, backhone a.toms: N, C", C'. 
(0·07) 
(0·06) 
(0·14} 
(0·05) 
(0·17) 
(0·201) 
1ßßN-+1RCB 
(A) 
Ours-+lRCß 
(A) 
1·30 1·58 
1·02 1·31 
1·07 (}84 
2·32 1·87 
0·85 0·71 
1·90 1·79 
gations available from the Brookhaven Data Bank, 
liTL (Smith et al., 1992), and IBBN (Powers et al., 
1993), as well as to a crystal structure, 1RCB 
(Wlodawer et al., 1992) on the basis of r.m.s.d. 
values (Table I). On the whole, the comparison of 
the NMR structures with each other and with the 
crystal structure IRCB shows a similar Ievel of 
accuracy for the three NMR structures. Com paring 
backhone atoms (C' ,G',N) for the residues 5 to 125, 
the three NMR structures diverge by values of 
l·30A (lBBN), l·58A (our structure), and 1·59A 
(IITL) from the X-ray structure (IRCB). Our struc-
ture shows an r.m.s.d. of 1·98 (liTL) and 1·68 
( l BBN) to the other NMR structures. There are two 
individual regions which merit some closer inspec-
tion, that is the region with the tryptophan, whose 
position is highly dependent on the assignment of 
A49, and the region araund tyrosine 124. The region 
88 to 98 of our structure shows a small, but signifi-
cantJy smaJler r.m.s.d. to the X-ray-structure lRCB 
when backhone atoms are compared, but a much 
better definition, when all heavy atoms are 
compared (Table l ). The reason for this is the con-
siderable nurober of NOE between A49 and W91 
found in our spectra. In fact, the position of the 
side-chain of W9l is exactly the same in our 
structure as in the X -ray structure. 
The structure araund Yl24 is important for the 
initiation of signal transduction and is hence a 
potential target for drug design. The area around 
this tyrosine (5--.14, ll6--+l25) deviates in our 
structure by 0·71 A from the X-ray structure, when 
backhone atoms are compared, and by 1·79 A, when 
all heavy atoms are compared. The other two NMR 
structures show similar deviations from the X-ray 
structure (Table I). The side-chain of Yl24 is posi-
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Figure 4. Enlargement of the region around Yl24 taken from the minimized· averaged structure (st.ereoplot). The 
medium and long range NOE defining this part of the structure are indicated by blue lines. 
tioned in the contact area between helices A and D, 
exposing part of the aromatic ring (approximately 
40%), and the OH group, to the solvent, forming a 
hydrophobic region on the surface of the protein. 
The position of Yl24 is defined by hydrophobic 
interactions with the side-chains of L7 and Ill, the 
latter also showing some solvent accessibility. On 
the surface around the site of Y124, a number of 
hydrophilic residues are positioned, i.e. Rl21, 8125, 
and Q8. There is a considerable number of NOE 
involving Yl24 (Figure 4, Table 2). Its ring is partly 
protec~d by the side-chains of Ill and Rl2l. The 
side-chain of Rl2l shows NOE between its C"H and 
the C6H methyl group of 111, which defines the 
position of its CIZ-C6-fragment. The guanidinium 
group, however, does not show any NOE to Yl24, 
which would be expected from the X-ray structure. 
In particular, the NeH of R121 and the aromatic 
protons of Yl24 should show strong NOE if a rigid 
structure, as present in the X -ray structure 
involving a hydrogen bond between Rl21 and Q8, 
Table 2 
Long-Tange N 0 E between helices A, 0 and D around 
the m utation site 
A c wt Yl24G Y124D 
Thr6 Leu93 m m m 
Leu7 Leu93 m m m 
IlelO Asn89 s 8 s 
IlelO Leu93 8 sfm 
Thrl3 Phe82 s 8 
A D wt Y124G Yl24D 
Lysl17 Leul4 s s 
Met120 llell w 
Metl20 l..eul4: m m m 
Metl20 Leu93 m '? m 
Argl21 Ilell sfm m m 
Xl24(HCE) Leu7 mfw mfw ·w 
The intensity of the strongest NOE between the indicated 
residues is given (s, strong; m, medium; w, wea.k; sfm, wfm, at the 
transit.ion point; 1, not available due to spectral overlap; , not 
observed, proba.bly for rea.sons of different signalfnoise. 
would exist in solution. There are a number of NOE 
defining the orientations of helices A, B, C and D 
with respect to each other in this a.rea (Table 2). 
These are the potential indicators for structural 
changes in the variants. 
(b) Variants Y124G and Y124D 
The variants Yl24G and Yl24D were investi-
gated to determine the nature of the structural 
changes resulting from these Substitutions. Thc 
NMR spectra of both variants show similar 
chemical shifts for most of the residues compared to 
the wild-type, suggesting strong similarity in their 
overall structures. For both variants, larger 
chemical shift changes were only observed towards 
the C and N terminus. T n fact, chemical shift devia-
tions smaller than 0·1 p.p.m. are observed for the 
residues II to 120 of Yl24G, indicating that no 
large-sca.Je structural changes are present. Similar 
observations were made for Yl24D. However, in the 
region of the substitution greater effects on the 
chemical shifts were observed. This is expected for 
the Substitution of an aromatic side-chain as it has a 
]arge anisotropic effect. 
The local NOE pattern of the regions I to 9 and 
120 to 124 in the variant Yl24G shows the conser-
vation of oc-helical structures around the substitu-
tion site. The secondary structure appears to be 
identical to that of the wild-type, where helix A 
starts at 15, and the end of helix D can be located at 
8125. This is indicated for helix A by the sequential 
NOE of the type NH;NH;+t• as weil as by the 
presence of the NOE ofthe type a1NHi+J• involving 
15 and Q8 (Figure 5). Helix D extends up to 8125, 
as can be concluded from the NHiNH1+ 1 NOE 
observed, and from a number of Iong range NOE 
which are also found in the wild-type (Figure 4), 
involving for example L7 and G 124 (Table 2). 
The variant Y124D shows a pattern of secondary 
structure (Figure 5) and long range NOE for helices 
A and D which is similar to that of the wild-type 
and variant YI24G. A comparison of the very 
pronounced NOE of the type aiZ/Ii+J between 
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Figure 5. Secondary structure pattern of the wild-type IL-4 and the variants Y124D and Yl24G. The NOE are 
classified according to intensities in NOESY spectra with mixing times of 80 to 100 ms. For the wild-type 11-4, data 
from 2D-NOESY and the 1'N-H..MQC-.NOESY were used, for the variants only data from unlabelled samples are shown. 
residues 121 and 124 and those of the type 
NHiNHi+ 1 between residues 124 and 125 shows that 
helix D also extends up to Sl25 in the variant 
YI24D. The NOR between L7 and Dl24 are also 
observed, although these are somewhat weaker. 
All other long range NOE are of comparable size 
(Table 2). 
4. Discussion 
The secondary and overal1 tertiary structure in 
both variants is not . perturbed, therefore the 
changes in the activity profile of the mutants 
Yl24G and Yl24D are related to interactions of the 
receptor with the tyrosine side-chain and its 
environment, potentially RI21 and Sl25. This is 
supported by the activity pattern of the Yl24 
variants. The ability to stimulate cell proliferation 
drops within the sequence WT, Yl24F, 
Yl24H> > Y124G, YI24K, YI24N> > Yl24D 
(Kruse et al., 1992). The fact that variants with 
aromatic acids in place of Yl24 show nearly wild-
type activity and the conservation of the structure 
in the YI24G and Y124-D lrariants suggests the 
importance of a hydrophobic region formed by part 
of the aroma.tic ring of YI24 for receptor binding. 
The mutations do not infl.uence the A-C site of the 
hormone, which explains the unaltered binding 
properties. These results are in contradiction to 
those reported in recent investigations 
(Bamborough et al., 1993; Powers et al., 1993; 
Wlodawer et al., 1993 ). They proposed tha.t the role 
of Yl24 is to stabilize the surrounding of the helical 
structure and that the changes in the activity 
profile observed for YI24G and Yl24D are due to a 
loss of structural integrity in this region. In support 
of this, mechanisms for breaking a helix through 
glycine or aspartic acid are known, and a docking of 
the high-affinity IL-4 receptor model to the A-D site 
of the hormone did not Iead to contacts between the 
receptor and the environment of Yl24. 
The functionally important region of the struc-
ture, the putative recognition site(s) for the recep-
tor(s), is given by the structurally well defined 
D-A-C face of the hormone. This is based on the 
analogy to the growth hormone, and the modified 
activity of the mutants E9Q/K (helix A) and 
R88Q/D (helix C), which showed reduced binding 
activity (Kruse et al., 1994); the variant Yl24D 
(helix D), which showed a strongly antagonistic 
activity, and the mutants Rl2ID, Yl24G and 
SI25D, which were only partial antagonists. The 
mutations HIQ, D4N, E26Q, E4IQ, E43Q, R47Q, 
R53Q, H59Q, K61Q, R85Q, El03Q, E114Q, 
Kll7Q, Kl23D, and Sl28D showed no effect. 
Figure 6 shows a view of the D-A-C helix interface. 
Amino acid substitutions without any effect are 
shown in blue, those which resulted in reduced 
binding activity are colonred yellow, and those 
which Iead to an antagonistic activity profile are 
coloured red. In light of the model of receptor 
oligomerization, the A-C face (Figure 6(c)) would 
Figure 6. Space-filling model of IL-4 showing a view onto the D-helix (a), the helices A and D (b), and the helices A and C (c). The sites where mutations did not show any 
effect a.re displa.yed in hlue, muta.tions lea.ding to reduced binding properties a.re indica.ted in yellow, a.nd sites where muta.tions with a.nta.gonistic activity were observed a.re 
shown in red. 
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Figure 7. Sequence alignment of (a) IL-4 and GM-CSF, and (b) IL-4 and hGH derived from a structure comparison 
using the program WHATIF (Vriend & Sander, 1991). In the case ofthe compa.rison ofiL-4 and hGH, an automatic best 
fit of the st.ructures was generated by maximizing the superposition of common structural elements (Vriend & Sander, 
1991 ). Forthose residues which were structurally not further apart from each other than 2·0 A, a maximum of sequence 
identity (7%) was obtained. Further support for the sequence alignment deduced from the superposition of the 
structures is given by the alignment offunctionally important residues, i.e. Nl2 ofhGH aligns with E9 of TL-4-, as weil as 
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then be primarily responsible for the binding of the 
first receptor molecule, whereas the A-D face 
(Figure 6(a)) would bind the second one, initiate 
dimerization of the receptor, and hence be respon-
sible for the signal. Surprisingly, the amino acid 
Substitutions leading to an altered activity profile 
are located in relatively narrow areas. 
The mutations on the A-C side of the hormone 
Iead to interesting conclusions concerning the 
inßuence of charges and of the electrostatic proper-
ties of the surface of the protein. The strongest 
effects for the E9 and R88 mutants are observed 
when the charge is reversed. The introduction of a 
glutamine at either position Ieads to a noticeable, 
but not dramatic, effect on the J!JC so value. I t rises 
from 200 pM to a value of 2000 pM in the case of 
R88 and 1400 pM for E9. The effect becomes 
dramatic upon charge reversal (EC50 =260,000 pM 
for E9K and 69,000 pM for R88D) (Kruse et al., 
1994). A similar effect is observed for the substitu-
tions of Yl24, where the introduction of a negative 
charge Ieads to the strongest antagonist. An inspec-
tion of the electrostatic properties of the protein 
surface reveals a very uneven distribution of 
charged amino acids; the solvent-exposed side of 
helix C contains many positively charged residues 
(K77, R81, K84, R85, and R88) (Wlodawer et al., 
1992), while a patch of negatively charged residues 
is observed in the region around the ß-sheet, the 
beginning of helix D, and the end of helix A. The 
negatively charged region is made up of the residues 
El9, E26, D31, EllO and Ell4. A comparison of 
the electrostatic properties of IL-4 with those of 
other cytokines allows conclusions to be drawn 
concerning whether two like or two unlike receptor 
molecules may be bound by the hormone (E. 
Demchuk, T. Müller, W. Sebald, H. Oschkinat and 
R. Wade, unpublished). In fact, the known lL-4 
receptor which shows a nurober of negatively 
charged residues in the contact area should bind 
only to the A-C face of IL-4. 
The results of the mutation experiments can be 
compared to other lymphokines by a structure and 
sequence comparison between lL-4, GM-CSF and 
hGH. A comparison of hGH and IL-4 is of special 
interest, as a number of point mutational data on 
hGH are available (Cunningham & Wells, 1989, 
1991) which may be compared to the mutational 
data on IL-4, and the structure of the hGHfreceptor 
complex provides a molecular. basis for examining 
hormone-receptor interactions. A comparison seems 
justified, despite the difference in size between the 
contact surface of the hGH (4500 A 2 ) and IL-4 
(2400 A 2 ), since the A-C face of the IL-4 is of similar 
size to that in hGH, and the A-D face of IL-4 
matches the size of the area important for activity 
on the A-D side of hGH as defined by site-directed 
mutagenesis experiments (Cunningham & Wells, 
1989, 1991 ). 
The comparison of all three structures shows that 
the individual helices have rather different lengths 
but the angles between helices A, C and D are very 
similar. The interhelix angles between these three 
helices and helix B, which seems not to be impor-
tant for receptor binding, vary to a larger extent. 
Comparison between IL-4 and GM-CSF (Figure 
7(a)) shows first of all the major role played by E9 
in TL-4 and E2l in GM-CSF (Meropol et al., 1 992), 
which in fact are Jocated in the same place in the 
aHgned sequences. For other mutagenesis experi-
ments on GM-CSF the effects are more difficult to 
explain in terms of receptor-hormone interactions, 
because they involve either tripeptide deletions 
(Shanafelt & Kastelein, 1989), the synthesis of 
chimeric mouse/human proteins (Kaushansky et al., 
1989) or proline scanning (Altmann et al., 1991). In 
all cases, larger structural rearrangements are 
expected. An example is the comparison of 
mutations on helix C, where the IL-4 mutants 
R88Q/D show very different binding properties, and 
the substitutions R85Q and W91R are rather 
neutral. The experiments with the chimeric proteins 
on GM-CSF show that residues in the region 78 to 94 
(GM-CSF numbering) (Kaushansky et al., 1989) are 
responsible for the activity, but the active site 
cannot be localized further. 
An independent comparison between hGH and 
IL-4 (Figure 7(b)) may be made on the basis of 
results from mutational studies (see symbols above 
the sequence of hGH and below the sequence of 
IL-4) and on the basis of the residues structurally 
involved in receptor-hormone interactions (de Vos et 
al., 1992). The latter are indicated within the 
sequence of hGH. The mutational studies firstly 
demonstrate that substitutions on the D helix in 
hGH affect the binding affinity (Cunningham & 
Wells, 1989), whereas mutations on that side in IL-4 
Iead to antagonistic activity, and vice ver Ba for the 
A-C face. This indicates that the hormonesbind the 
receptor molecu1es in a different order. Despite this 
difference, similar interactions with the receptor 
molecules seem to occur. The binding affinity of 
Ell9 with R88, Rl78 with Rl21, and Ql81 with Yl24 of hGH and IL-4. The residues directly involved in receptor 
binding and the residues found to be important in mutational studies are indicated. An automatic alignment did not 
yield the highest possible sequence homology for IL-4 and GM-CSF. Therefore, the alignment was performed manually 
by superimposition of the structures so that the residues not further away from each other than 2·0 A in both proteins 
showed a maximum sequential identity. Simultaneous1y, a good fit was obtained for the common motif in the 2 
structures made up by the helices A and D, the ß-sheet, and the loops connecting the 2 helices and the sheet. The residues 
in the superimposed structures which show an r.m.s.d. less than 2·0 Aare printed with a reduced spacing. The mutational 
data on hGH and IL-4 are included aa symbols above or below the sequences. Circles indicate mutations tha.t Iead to 
reduced binding properties, squares indicate sites where mutations produced an antagonistic activity. For hGH, the 
residues directly involved in receptor binding are indicated within the sequence by circles (first binding receptor 
molecule) and squares (second receptor molecule). The helical regions are shaded. 
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IL-4 to its known receptor is strongly affected by 
the residues E9 and R88Q, and the corresponding 
residues Nl2 and Ell9 play a major role in hGH (de 
Vos et al., 1992; Cunningham & Wells, 1991). 
Unexpectedly,,substitutions ofR85 in IL-4 have no 
effect, although the corresponding residue in hGH 
(Dll6) is directly involved in receptor bindingvia a 
salt bridge and its replacement by alanine shows 
)arger effects on the activity than a substitution of 
Ell9. The roJe of the N terminus may be different 
for both proteins, as the Substitution HJQ in IL-4 
showed no effect, whereas I4 variants of hGH 
showed large differences in activity compared to the 
wild-type. 
The epitope on the D-helix defining the area 
primarily important for the binding of the first 
receptor molecule in hGH (Cunningham & WeHs, 
1989) is in a similar position to the site in IL-4, 
where mutations Iead to an antagonistic activity. In 
fact, the substitution of Rl21 in IL-4 leads t,o a 
result equivalent to the substitution of Rl78 in 
hGH. The effects observed for the substitution of 
Cl82 in hGH are in agreement with those observed 
for 8125 in IL-4. The strong effect observed for 
Yl24 in IL-4 has no correspondence in hGH, which 
is surprising considering the localized structural 
effect of the mutations in IL-4 (see above). In the 
same manner, the neutrality of the substitutions of 
K 117 in IL-4 is not expected from the comparison 
with hGH. However, substitution with a negatively 
charged residue would be expected to show great.er 
effects. An estimate of the interactions of two 
receptor molecules of the haematopoietin type with 
IL-4 can be obtained from comparison with the 
hGHfreceptor complex. The site of hGH which 
binds the first receptor molecule is the A-D face 
involving the residues HIS and F25 on helix A, and 
RI67, Kl68, Dl71, Tl75, Rl78, and CI84 on helix 
D, neglecting the residues located in the insertion. 
In IL-4, the residues EllO, Nlll, Ell4, and Tll8 
should interact with a receptor molecule in addition 
to Rl2l, Yl24 and 8125, and hence be potential 
candidates for generating antagonis~ic activity. 
Appropriate substitutions of Nl5 m IL-4 could have 
similar effects. The substitution Ell4Q, however, 
did not lead to a change in activity of IL-4. The A-C 
face of hGH contributes the residues T3, I4, L6, 
Nl2, Ll5, Rl6, Rl9, Q22, YI03, Dll6 and Ell9 to 
receptor binding. The alignment of the hGH and 
IL-4 sequences provides an explanation for the 
finding that the IL-4 mutants E9K. and R88D ~~ow 
strongly reduced binding propert1es. In add1t10n, 
appropriate substitutions of K12, T13, 816, El~, 
and R85 should show similar effects. The results 
allow some conclusions to be made concerning the 
mode of receptor binding of IL-4. Firstly, the A-C 
face in IL-4 binds first to a single molecule of the 
known TL receptor. 8econdly, the strong similarity 
of the A-D side, including the ß-sheet, in IL-4 and 
GM-CSF is striking. This could mean that a second 
receptor molecule, related to the GM-CSF receptor, 
binds to that side of TL-4. Support for this argu-
ment comes from the different distribution of 
charged residues on both sides of the hormone. The 
surface of helix C is strongly dominated by posi-
tively charged residues, and a large negative region 
is observed on the A-D side in the area of the 
ß-sheet, the loops to the helices A and D, and at the 
beginning of helix D. This suggests that the binding 
of IL-4 to the known IL-4 receptor, which has 
negatively charged residues in the proposed binding 
area (Fernandez-Botran & Vitetta, 1990; Bazan, 
l990c) to this face on IL-4 is implausible. 
This work ·was supported by the Deutsche 
Forschungsgemeinschaft (grant Se 435/4-1 ). We thank 
H. Spengler for the preparation of the variant proteins 
Y124G and Y124G and Dr M. Buehner for helpful discus-
sions. The structures were displayed with QUANTA 
(Molecular Simulations Inc.). 
References 
Altmann, S. W., .Johnson, G. D. & Prystowsky, M. B. 
(1991). Single proline substitutions in predicted 
alpha-helices of murine granulocyte-macrophage 
colony-stimulation factor result in a loss in bio-
activity and altered glycosylation. J. Biol. Chem. 
266, 5333-534-1. 
Aue, W. P., Bartholdi, E. & Ernst, R. R. (1976). 
Two-dimensional spectroscopy. Application to 
nuclear magnetic resonance . .J. Chem. Phys. 64, 
2229-2246. 
Bamborough, P., Grant, 0. H., Hedgecock, C .• J. R., 
West, S. P. & Richards, W. G. (1993). A computer 
model of the interleukin-4-/receptor complex. 
P-roteins, 17, ll-19. 
Bazan, J. F. (1990a). Structural design and molecular 
evolution of a cytokine receptor superfamily. Proc. 
Nat. Acad. Sei., U.S.A. 87, 6934-6938. 
Bazan, J. F. (1990b). Haemopoietic receptors and helical 
cytokines. Immunology Today, 11, 35()---354. 
Bazan, J. F. (1990c). Structural design and molecular 
evolution of a cytokine receptor superfamily. Proc. 
Nat. Acad. Sei., U.S.A. 81, 6934-6938. 
Boula.y, J.-L. & Pa.ul, W. E. (1992). The interleukin-4-
related lymphokines and their binding to hemato-
poietin receptors. J. Biol. Chem. 267, 20525-20528. 
Brünger, A. T. (1992). X-PLOR. A System jor X-ray 
Cry.9tallography and NMR. Yale University Press, 
New Haven. 
Burstein, H. J ., Tepper, R. 1., Leder, P. & Abbas, A. K. 
(1991). Humoral immune functions in IL-4 trans-
genic mice. J. Immunol. 147, 295o-2956. 
Cabrillat, J., Galizzi, J.-P., Djossou, 0., Arai. N., Yokota, 
T., Ara.i, K. & Banchereau, J. (1987). High affinity 
binding of human interleukin-4 to cell lines. Biochem. 
Bi(yphys. Re8. Gommun. 149, 995-1001. 
Cantrell, D. A., Collins, M. K. & Crumpton, M .• J. (1988). 
Autocrine regulation of T-lymphoc:yte proliferation: 
differential induction of Tl-2 and Il-2 receptor. 
Immunology, 65, 343-349. 
Clore, G. M., Kay, L. E., Bax, A. & Gronenborn, A. M. 
(1991). Four dimensional 13C/l3C-edited nuclear 
Ovarhauser enhancement spectroscopy of a protein in 
solution: application to interleukin I b. Biochemistry, 
30, 12-18. 
Coffman, R. T.. ... , Ohara, J., Bond, M. W., Carty, J., 
Zlotnik, A. & Paul, W. E. (1986). B-cell stimulatory 
factor-1 enhances the TgE response of lipopoly-
sacch~ride-activated B-cells J. lmmunol. 136, 
4538-4541. 
Receptor Binding and Signalling of I nterleukin-4 435 
Cosman, D., Lyman, S. D., ldzerda, R. L., Beckman, 
M. P., Park, L. S., Goodwin, R. G. & March, C. J. 
(1990). A new cytokine receptor superfamily. Trends 
Biochem. Sei. 15, 265-270. 
Cunningham, B. C. & Wells, J. A. (1989). High-resolution 
epitope mapping of hGH-receptor interactions by 
alanine-scanning mutagenesis. Science, U.S.A. 244, 
1081-1085. 
Cunningham, B. C. & Wells, J. A. (1991). Rationaldesign 
of receptor-specific variants of human growth 
hormone. Proc. Nat. Acad. Sei., U.S.A. 88, 
3407-3411. 
Cunningham, B. C., Ultsch, M., de Vos, A. M., Mulkerrin, 
M. G., Clauser, K. R. & Wells, J. A. (1991 ). 
Dimerization of the extracellular domain of the 
human growth hormone receptor by a single hormone 
molecule.Science, U.S.A. 254, 821-825. 
de Vos, A. M., Ultsch, M. & Kossiakoff, A. A. (1992). 
Human growth hormone and extracellular domain of 
its receptor: crystal structure of the complex. Science, 
255, 306-312. 
De Vries, ,J. E., Gauchat, .J. F., Aversa, G. G., Punnonen, 
J., Gascan, H. & Yssel, H. (1991). Regulation of IgE 
synthesis by cytokines. Gurr. Opin. Immunol. 3, 
851-858. 
Defrance, T., Vanvesliet, B., Anbry, J. P., Takebe, Y., 
Arai, N., Miyajima, A., Yokota, T., Lee, F., Arai, 
K. 1., de Vries, J. E. & Banchereau, J. (1987). B-eeil 
growth promoting activity of recombinant human 
interleukin-4. J. Immunol. 139, 1135-1141. 
Diederichs, K., Boone, T. & Karplus, P. A. (1991 ). Novel 
fold and putative receptor binding site of granulo-
cyte-macrophage colony-stimulating factor. Science, 
254, 1779-1782. 
Dullens, H. F. & DeWit, C. L. (1991). Cancertreatment 
with interlenkins I, 4 and 6 and combination of 
cytokines: a review. In Vivo, S, 567-570. 
Fanslow, W. C., Spriggs, M. K., Rauch, C. T., Clifford, 
K. N., Macduff, B. M., Ziegler, S. F., Schooley, K. A., 
Mohler, K. M., March, C. J. & Armitage, R. J. (1993). 
ldentification of a distinct low-affinity receptor for 
human interleukin-4 on pre-ß cells. Blood, 81, 
2998-3005. 
Fernandez-Botran, R. & Vitetta, E. S. (1990). A soluble, 
high-affinity, interleukin-4-binding protein is present 
in the biological fluids of mice. Proc. Nat. Acad. Sei., 
U.S.A. 87, 4202-4206. 
Finkelman, F. D., Holmes, J., Katona., I. M., lJrban, 
• J. F., Beckmann, M. P., Park, L. S., Schooley, K. A., 
Coffman, R. L., Mosmann, T. R. & Paul, \V. E. 
(1990). Lymphokine control of in vivo immuno-
globulin isotype selection. Annu. Rev. lmmunol. 8, 
303-333. 
Fukunaga, R., Ishizaka-Ikeda, E., Seto, Y. & Nagata, S. 
(1990). Expression cloning of a receptor for murine 
granulocyte colony-stimulating factor. Cell, 61, 
341-350. 
Galizzi, J. -P., Zuber, C. E., Harada, N., Gorman, D. M., 
Djossou, 0., Kastelein, R., ßanchereau, ,J ., Howard, 
M. & Miyajima, A. (1990). Molecular cloning of a 
cDNA encoding the human interleukin-4 receptor. 
lnt. lmmunol. 2, 669-675. 
Garrett, D. S., Powers, R., March, C. J., Frieden, E. A., 
Clore, G. 1\f. & Gronenborn, A. M. (1992). 
Determination of the secondary structure and folding 
topology of human intedeukin-4 using three-dinten-
sional heteronuclear magnetic resonance spectro-
scopy. BüJr-he-mistry, 31, 4347-4353. 
Griesinger, C., Otting, G., Wüthrich, K. & Ernst., R. R. 
(1988). Clean TOCSY for I H spin systern identific.~a-
tion in macromolecules. J. Amer. Chem. Soc. llO, 
7870-7872. 
Harada, :N., Castle. B. E., Gorma.n, D. M., Itoh, N., 
Schreurs, J., Barrett, R. L., Howard, M. & Miyajima. 
A. (1990). Expression c!oning of a cDNA encoding 
the murine interleukin-4 receptor ba.sed on Iigand 
binding. Proc. Nat. Ar..ad. Sei., U.S.A. 87, 857-861. 
Hayashida, K. (1990). Molecular cloning of a second sub-
unit of the receptor for human granulocyte-macro-
phage colony-stimulating factor (GM-CSF): 
Reconstitution of a high-affinity GM-CSF receptor. 
Proc. Nat. Acml. Sei., U.S.A. 87, 9655-9659. 
ldzerda, R. L., March, C. J ., Mosley, B., Lyman, S. D., 
Vanden-Hos, T., Gimpel, S. D. & Din, W. S. (1990). 
Human interleukin 4 receptor confers biological 
responsiveness and defines a novel receptor super-
family. J. Exp. MP.d. 171, 861-873. 
Jansen, .J. H., Fibbe, W. E., Willemze, R. & Kluin-
Nelemans, J. C. (1990). Interleukin-4. Blut, 60, 
269-274. 
Jeener, ,J., Meier, B. H., Bachmann, P. & Ernst, R. R. 
(1979). lnvestigation of exchange processes by two 
dimensional NMR spectroscopy. J. Ohem. Phys. 71, 
4546-4553. 
Kastelein, R. A. & Shanafelt, A. B. (1993). GM-CSF 
receptor: interactions and activation. Oncogene, 
U.S.A. 8, 231-236. 
Kaushansky, K., Shoemaker, S. G., Alfaro, S. & Brown, 
C. (1989). Hematopoietic activity of granulocyte-
macrophage colony stimulating factor is dependent 
upon two distinct regions of the molecule: functional 
analysis based upon the activities of interspecies 
hybrid growth factors. Proc. Nat. Ar,ad. Sei., U.S.A. 
86, 1213-1217. 
Kruse, N., Lehrnbecher, T. & Sebald, W. (1991). 
Site-directed mutagenesis reveals the importance of 
disulfide bridges and aromatic residues for structure 
and proliferate activity of human interleukin-4. 
FEBS Letter8, 286, 58-60. 
Kruse, N., Tony, H.-P. & Sebald, W. (1992). Conversion 
of human interleukin-4 into a high affinity antagonist 
by a single amino acid replacement. EMRO J. 11, 
3237-3244. 
Kruse, .N., Shen, B., Arnold, S., Tony, H.-P.~ Müller, 'I'. & 
Sebald, W. (1994). Two distinct functional sites of 
human interleukin-4 are identified by variants 
impaired in either receptor binding or receptor 
activation. EM BO J. 12, 5121-5129 . 
1\iarion, D., Kay, I~., Sparks, S. W., Torchia, P. A. & Bax, 
A. (1989). 3-Dimensional heteronuclear NMR of N15 
labeled proteins. J. Amer. Ohern. Soc. 111, 
1515-1.517. 
McKay, D. B. (1992). Response to article: unraveling the 
structure of l-L-2. Science, 251, 412-413. 
M:eropol, N .• J., Altmann, S. \V., Shanafelt, A. ß., 
Kastelein, R. A., ,Johnson, G. D. & Prystowsky, 
1\I. B. (1992). Requirement of hydrophilic amino-
terminal residues for granulocyte-macrophage 
colony-stimulating factor bioactivity and receptor 
binding. J. Biol. Chem. 261, 14266-14269. 
1\-lorl'ison, B. \V. & Leder, P. (1992). A receptor binding 
domain of mouse interleukin-4 defined by a solid-
phase binding assay andin vüro mutagenesis. J. Biol. 
Ohem. 267, 11957-ll963. 
Mosley, B., Heckmann, M. P., March, C. J., Idzderda, 
R. L .. Gimpel, S. D., Vandenßos, T., Friend, D., 
Alpert, A., Anderson, D. & .Jackson, J. (1989). The 
murine interleukin-4 reeeptor: molecular cloning and 
characterization of secreted and membrane bound 
forms. Cell, 59. 3:35-348. 
436 Receptor Binding and Signalling of I nterleukin-4 
.Mott, H. R., Driscoll, P. C., Boyd, J., Cooke, R. M., Weir, 
M. P. & Campbell, I. D. (1992). Secondary structure 
of human interleukin 2 from 3D heteronuclear NMR 
experiments. Biochemistry, 31, 7741-7744. 
Neidig, K.-P., Saffrich, R., Lorenz, M. & Kalbitzer, H. R. 
(1990). Clusteranalysis and multiplet pattern recog-
nition in two-dimensional NMR spectra. J. M agn. 
Reson. 89, 543-552. 
Nilges, M., Kuszewski, J. & Brünger, A. T. (1991). 
Sampling properties of simulated annealing and 
distance geometry. In Oomputaticmal Aspect8 of the 
Study oj Biological M acromolecules by N uclear 
Magnetic Resonance Speclroscopy (Hoch, J., et al., 
eds), Plenum Press, New Y ork. 
Oschkinat, H., Cieslar, C. & Griesinger, C. (1990). 
Recognition of secondary structure elements in 3D 
TOCSY-NOESY spectra of proteins. J. Magn. Reson. 
86, 453-469. 
Park, L. S., Friend, D., Sassenfeld, H. M. & Urdal, D. L. 
(1987). Characterization of the human B cell stimula-
tory factor 1 receptor. J. Exp. Med. 166, 476-488. 
Paul, W. E. (1987). Interleukin 4/B cell stimulatory factor 
1: one lymphokine, many functions. F ASEB J. 1, 
456-461. 
Paul, W. E. (1991 ). Interleukin-4: a prototypic immuno-
regulatory lymphokine. Blood, 77, 1859-1870. 
Paul, W. E. & Ohara, J. (1987). B-eeil stimulatory factor-
1/interleukin-4. Annu. Rev. Immunol. S, 429-459. 
Powers, R., Garrett, D. S., March, C. J., Frieden, E. A., 
Gronenborn, A. M. & Clore, G. M. (l992a). IH, 15N, 
130 and 13CO assignments of human interleukin-4 
using three-dimensional double- and triple-resonance 
heteronuclear magnetic resonance spectroscopy. 
Biochemistry, 31, 4334--4346. 
Powers, R., Garrett, D. S., March, C. J., Frieden, E. A., 
Gronenborn, A. M. & Clore, G. M. (1992b). 
Three-dimensional solution structure of human inter-
leukin-4 by multidimensional heteronuclear magnetic 
resonance spectroscopy. Science, 256, 1673-1677. 
Powers, R., Garrett, D. S., March, C. J., Frieden, E. A., 
Gronenborn, A. M. & Clore, G. M. (1993). The high 
resolution, three-dimensional solution structure of 
human interleukin-4 determined by multi-
dimensional heteronuclear magnetic resonance 
spectroscopy. Biochemistry, 32, 6744-676i>.. · 
Redfield, C., Smith, L. J., Boyd, J., Lawrence, G. M. P., 
Edwa.rds, R. G., Smith, R. A. G. & Dobson, C. M. 
(1991). Secondary structure and topology of human 
interleukin 4 in solution. Biochemistry, 30, 
11029-11035. 
Redfield, C., Boyd, J., Smith, L. J., Smith, R. A. G. & 
Dobson, C. M. (1992). Loop mobility in a four-helix-
bundle protein: NMR relaxation measurement.s on 
human interleukin-4. Biochemistry, 31, 10431-10437. 
Sakamaki, K., Miyajima, 1., Kitamura, T. & Miyajima, A. 
(1992). Critical cytoplasmic domains of the common 
ß subunit of the human GM-CSF, IL-3 and IL-5 
receptors for growth signal transduction and tyrosine 
phosphorylation. EMBO J. 11, 3541-3549. 
Sanderson, C. J., Campbell, H. D. & Young, I. G. (1988). 
Mole<:ular and cellular biology of eosinophil differen-
tiation factor (interleukin-5) and its effects on human 
and mouse B cells. Immunol. Rev. 102, 28-50. 
Shanafelt, A. B. & Kastelein, R. A. (1989). ldentification 
of critical regions in mouse granulocyte-macrophage 
colony-stimulating factor by scanning-deletion 
analysis. Proc. Nat. Acad. Sei., U.S.A. 86, 
4872-4876. 
Shanafelt, A. B., Miyajima, A., Kitamura, T. & Kastelein, 
R. A. (1991). The amino-terminal helix of GM-CSF 
and IL-5 governs high affinity binding to their recep-
tors. EM BO J. 10, 4105-4112. 
Smith, L. J., Redfield, C., Boyd, J., Lawrence, G . .M., 
Edwards, R. G., Smith, R. A. & Dobson, C. M. 
(1992). Human interleukin 4. The solution structure 
of a four-helix bundle protein. J. Mol. Biol. 224, 
899-904. 
Tepper, R. I., Pattengale, P. K. & Leder, P. (1989). 
Murine interleukin-4 displays potent anti-tumor 
activity in vivo, Gell, 51, 503-512. 
Tepper, R. 1., Coffman, R. L. & Leder, P. (1992). An 
eosinophil-dependent mechanism for the antitumor 
effect of interleukin-4 Science, 251, 548-551. 
Vitetta, E. S., Ohara, J., Myers, C. D., Laylou, J. E., 
Krammer, P. H. & Paul, W. E. (1985). Serological, 
biochemical, and functional identity of B cell-stimu-
latory factor 1 and B cell differentiation factor for 
IgGl. J. Exp. Med. 162, 1726-1731. 
Vriend, G. & Sander, C. (1991). Detection of common 
three-dimensional substructures in proteins. Proteins, 
11, 52-58. 
Walter, M. R., Cook, \V. J., Zhao, B. G., Cameron, R. P., 
Jr, Ealick, S. E., Walter, R. L., Jr, Reichert, P., 
Nagabhushan, T. L., Trotta, P. P. & Bugg, C. E. 
(1992a). Crystal structure of recombinant human 
interleukin-4. J. Biol. Chem. 261, 20371-20376. 
Walter, M. R., Cook, W. J., Ealick, S. E., Nagabhushan, 
T. L., Trotta, P. P. & Bugg, C. E. (1992b). 
Three-dimensional structure of recombinant human 
granulocyte-macrophage colony stimulating factor. 
J. Mol. Biol. 224, 1075-1085. 
Watowich, S. S., Yoshimura, A., Longmore, G. D., 
Hilton, D. J.,. Yoshimura, Y. & Lodish, H. F. (1991). 
Homodimerization and constitutive activation of the 
erythropoietin receptor. Proc. Nat. Acad. Sei., 
U.S.A. 89, 2140-2144. 
Weigel, U.,•Meyer, M. & Sebald, W. (1989). Mutant pro-
teins of human interleukin 2. Renaturation yield, 
proliferative activity and receptor binding. Eur. J. 
Biochem. 180, 29~300. 
Willker, W. & Leibfritz, D. (1992). Precise determination 
of coupling constants with the JHH TOCSY experi-
ment, J. Magn. Reson. 99, 421-429. 
Wlodawer, A., Pavlovsky, A. & Gustchina, A. (1992). 
Crystal structure of human recombinant interleukin-
4 at 2·25A resolution. FEBS Letters, 309, 59-64. 
Wlodawer, A., Pavlovsky, A. & Gustchina, A. (1993). 
Hemopoetic cytokines: similarities and differences in 
the structures, with implications for receptor 
binding. Protein Sei., 2, 1373-1382. 
Zurawski, S. M. & Zurawski, G. (1989). Mouse interleukin 
2 structure-function studies: substitutions in the first 
alpha-helix can specifically inactivate p70 receptor 
binding and mutations in fifth alpha-helix can speci-
fically inactivate p55 receptor binding. EM BO J. 8, 
2583-2590. 
Edited by P. E. Wright 
( Received 23 June 1993; accepted 21 December 1993) 
